Ligand Pharmaceuticals Incorporated director just declared ownership of no shares of Ligand Pharmaceuticals Incorporated

Sarah Boyce, a director of Ligand Pharmaceuticals Incorporated, appears to have filed an empty initial statement of beneficial ownership. This form is usually filed as a prelude to a company officer either receiving options or buying company shares, so there may be more to come from Boyce.

Here is the filing.

To get notified when Ligand Pharmaceuticals Incorporated makes a similar move, sign up!

Other recent filings from the company include the following:

EVP of Ligand Pharmaceuticals Incorporated just picked up 238 shares - July 1, 2020
SVP of Ligand Pharmaceuticals Incorporated just picked up 238 shares - July 1, 2020
Confidential treatment order - June 15, 2020
Ligand Pharmaceuticals Incorporated director just picked up 831 shares - June 12, 2020
Ligand Pharmaceuticals Incorporated director just picked up 831 shares - June 12, 2020

Auto Refresh

Feedback